S Korean exosome biotech firm ILIAS Biologics raises $20.6m in Series B round

S Korean exosome biotech firm ILIAS Biologics raises $20.6m in Series B round

30 September, 2020

Asset One HB Investment ILIAS Biologics

Printed by Unregistered user on Tue, 16 Dec 2025 08:51:10 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

S Korean biotech firm Orum Therapeutics raises $30m in Series B round

South Korean AI-based pharma firm Oncocross secures $14m Series B

Read more from Rest of Asia

Elham Credit teams up with Digital Climate Group for private credit origination

Carlyle to buy Japanese surgical kits maker Hogy Medical for $1b